China Headache and Vertigo Registry Study
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jun 17, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The China Headache Registry Study is looking at different types of headaches, including migraines, tension-type headaches, and other related conditions like vertigo and fibromyalgia. This study aims to gather information from patients aged 4 to 99 years to better understand the causes, symptoms, and treatments of these headache disorders. Researchers will examine various factors, such as genetics and heart function, and plan to follow participants over the long term to see how their conditions change.
To participate in this study, individuals must provide written consent and be diagnosed with specific headache types according to established guidelines. The study welcomes both males and females who fit within the age range. Participants will be asked to keep track of their headaches, but those unable to do so or who cannot commit to long-term follow-up will not be eligible. Overall, this research aims to improve our understanding of headache disorders and help develop better treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
- • Male or female participants ages 4 to 99 years.
- • Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches.
- • Patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).
- Exclusion Criteria:
- • Patients who were unable to complete scales such as headache diary.
- • Patients denied or unable to be admitted for long-term follow-up.
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Kaiming Liu, Doctor
Principal Investigator
headache specialist clinic of the Second Affiliated Hospital of Zhejiang Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials